Mr. Mr. Collins and Michael Mr. Collins , Innate ’s chairman , said they had never heard of many of the company ’s more prominent investors , and said they first learned that Mr. Price had invested in the company from an article in The Wall Street Journal , which first reported his investment theyThey also said they had not heard of the company , the    shareholder , or Mr. Paxon and said they had little Mr. Price in they the ear they powerful Washington players .Their goal , they said , is to sell the company to they larger pharmaceutical company ."